Russian researchers have developed a non-invasive urinalysis-based test that may help monitor bladder cancer and reduce the need for frequent cystoscopy, a painful procedure used to examine the bladder. This test measures the protein survivin, which is associated with tumor activity, using an optical bioimmunoassay.